Home > D. Systemic pathology > Infectious diseases > HCV

HCV

Tuesday 7 October 2003

Pathology

- non-A non-B hepatitis
- type II cryoglobulinemia

- HCV-associated B-cell lymphomas

  • lymphoplasmacytoid lymphoma
  • immunocytoma-lymphoma
  • marginal zone lymphoma
  • splenic lymphomas
    • diffuse primary hepatosplenic large cell lymphoma
    • splenic lymphoma with vilous lymphocytes
    • splenic diffuse large B-cell lymphoma (DLBCL) (16112004)
    • splenic marginal zone lymphoma (SMZL)
    • hepatosplenic T-cell and natural killer cell lymphoma

Videos

- Hepatitis C virus

< object width="425" height="350"> < param name="movie" value="http://www.youtube.com/v/7pfR-zdiuds"> < /param> < param name="wmode" value="transparent"> < /param> < embed src="http://www.youtube.com/v/7pfR-zdiuds" type="application/x-shockwave-flash" wmode="transparent" width="425" height="350"> < /embed> < /object>

References

- De Clercq E. The design of drugs for HIV and HCV. Nat Rev Drug Discov. 2007 Dec;6(12):1001-18. PMID: 18049474

- Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The way forward in HCV treatment—finding the right path. Nat Rev Drug Discov. 2007 Dec;6(12):991-1000. PMID: 18049473

- Dubuisson J, Penin F, Moradpour D. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 2002 Nov;12(11):517-23. PMID: 12446113

- Moradpour D, Brass V, Gosert R, Wolk B, Blum HE. Hepatitis C: molecular virology and antiviral targets. Trends Mol Med. 2002 Oct;8(10):476-82. PMID: 12383770